ProJenX

ProJenX is a clinical-stage biotechnology company developing targeted therapies to address untreatable brain diseases, with an initial focus on ALS.

treasure map compass
Biotech

ProJenX ALS drug gets back on the map after partial FDA hold

ProJenX is back on the map after the FDA lifted a partial clinical hold on a phase 1 clinical trial for an amyotrophic lateral sclerosis drug.
Annalee Armstrong Mar 29, 2024 10:44am